leisure time -WSS

leisure time

author：comprehensive 2025-09-30 14:09:45 - browse：1

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — European regulators on Friday reiterated their view that an ALS treatment from Amylyx Pharmaceuticals should not be approved, likely dooming the drug’s chances for now.

A European Medicines Agency committee had initially recommended against approving the drug, known as Albrioza, in June. Friday’s confirmation of that position came after the company appealed the decision. While the European Commission officially decides whether to approve a new medicine, it almost always follows the committee’s guidance. The final decision is expected to be made before the end of the year.

The drug, which won approval last year in the United States and is marketed Relyvrio, is designed to slow the progression of the fatal neurological condition. In its pivotal trial, patients who received the drug over 24 weeks scored about two points better on a 48-point scale of symptoms than those who got a placebo, indicating the drug slowed disease progression.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Ambulance rides for just $100? Advisers want major billing fixes

WSS

A clever new way to fix Medicaid and graduate medical education

Ambulance rides for just $100? Advisers want major billing fixes

FDA approves Recor Medical high blood pressure device

Extreme heat events are a public health emergency

Study: New antibiotic targets gonorrhea as well as last existing drug

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

Wikipedia

leisure time

hotspot

Activists slam private health insurers over coverage restrictions

Leon Gautier, last member of French D

How one medical school became remarkably diverse

Leon Gautier, last member of French D

Medicare details structure of new drug price negotiation program

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Trump demands the U.S. pay no more for drugs than other countries … again

MoonLake credibility takes another hit with mid

Guidelines to prevent youth baseball injuries need more muscle

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

focus

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Removing probiotics from the NICU could threaten preemies' health

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

July 4th fireworks can be stressful for dogs. These 6 tips can keep them calm and safe

Abortion clinic in Cancun will cater to Americans

Will General Catalyst be the first of many hospital takeovers?

explore

entertainment

focus

focus